MBL Wealth Portfolio holdings
MBL Wealth is the investment management company that MBL Advisors launched in 2020, and MBL Advisors itself began in 1985 as an insurance advisory practice for high-net-worth families and business owners. Wachovia Bank acquired MBL Advisors in 1999; after Wells Fargo bought Wachovia in 2009, Luther Lockwood, who had joined in 1996, led it back to independence and it took the name MBL Advisors. Lockwood is chief executive of MBL Wealth. MBL Wealth builds long-term, goal-based portfolios spread across stocks, bonds and other assets. Its clients include individual investors, high net worth individuals, charities and pension and profit-sharing plans, and the wider firm puts particular emphasis on helping business owners plan for and hand over their businesses.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
F/m US Treasury 3 Month Bill Fund
TBIL
|
+$13.3M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$9.17M |
| 3 |
iShares iBonds Oct 2032 Term TIPS ETF
IBII
|
+$8.74M |
| 4 |
iShares iBonds Dec 2030 Term Treasury ETF
IBTK
|
+$8.5M |
| 5 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$16.5M |
| 2 |
Strategic Trust Running Oak Efficient Growth ETF
RUNN
|
+$2.4M |
| 3 |
JPMorgan Core Plus Bond ETF
JCPB
|
+$2.03M |
| 4 |
T. Rowe Price Dividend Growth ETF
TDVG
|
+$1.52M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.88% |
| 2 | Technology | 8.64% |
| 3 | Financials | 3.65% |
| 4 | Industrials | 2.51% |
| 5 | Healthcare | 2.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Royalty Pharma
RPRX
$30.6B
| $228K | 0.01% |
3,908
+266
| +7% | +$15.7K |
2026 Q2
1 quarter
|
|
552
AutoNation
AN
$5.72B
| $227K | 0.01% |
+1,441
| New | +$285K |
2026 Q3
0 quarters
|
|
553
Southwest Airlines
LUV
$22B
| $227K | 0.01% |
+5,448
| New | +$239K |
2026 Q3
0 quarters
|
|
554
Fidelity National Financial
FNF
$11.6B
| $226K | 0.01% |
+5,849
| New | +$278K |
2026 Q3
0 quarters
|
|
555
Toro Company
TTC
$10.1B
| $225K | 0.01% |
+2,332
| New | +$223K |
2026 Q3
0 quarters
|
|
556
Commercial Metals
CMC
$6.83B
| $224K | 0.01% |
+3,607
| New | +$243K |
2026 Q3
0 quarters
|
|
557
CVS Health
CVS
$113B
| $224K | 0.01% |
2,610
-229
| -8% | -$22.4K |
2026 Q1
2 quarters
|
|
558
Vanguard Health Care ETF
VHT
$21B
| $223K | 0.01% |
707
| – | – |
2026 Q2
1 quarter
|
|
559
Conductor Global Equity Value ETF
CGV
$132M
| $223K | 0.01% |
+14,254
| New | +$226K |
2026 Q3
0 quarters
|
|
560
JPMorgan Equity Premium Income ETF
JEPI
$46.3B
| $222K | 0.01% |
3,949
-5
| -0.1% | -$285 |
2025 Q4
3 quarters
|
|
561
AXIS Capital
AXS
$7.78B
| $222K | 0.01% |
+2,356
| New | +$245K |
2026 Q3
0 quarters
|
|
562
Caris Life Sciences
CAI
$6.54B
| $222K | 0.01% |
+7,242
| New | +$163K |
2026 Q3
0 quarters
|
|
563
PepsiCo
PEP
$197B
| $221K | 0.01% |
1,745
-785
| -31% | -$108K |
2025 Q3
4 quarters
|
|
564
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.74B
| $220K | 0.01% |
1,600
-100
| -6% | -$14.7K |
2023 Q4
11 quarters
|
|
565
The Ensign Group
ENSG
$11B
| $220K | 0.01% |
+1,280
| New | +$224K |
2026 Q3
0 quarters
|
|
566
Assured Guaranty
AGO
$3.24B
| $220K | 0.01% |
+3,249
| New | +$252K |
2026 Q3
0 quarters
|
|
567
Lennar Class A
LEN
$19.9B
| $220K | 0.01% |
+2,691
| New | +$226K |
2026 Q3
0 quarters
|
|
568
Saic
SAIC
$6.32B
| $220K | 0.01% |
+1,721
| New | +$212K |
2026 Q3
0 quarters
|
|
569
Extra Space Storage
EXR
$33.2B
| $218K | 0.01% |
+1,655
| New | +$238K |
2026 Q3
0 quarters
|
|
570
Moody's
MCO
$87.6B
| $218K | 0.01% |
+479
| New | +$232K |
2026 Q3
0 quarters
|
|
571
Citizens Financial Group
CFG
$27.2B
| $217K | 0.01% |
+3,406
| New | +$240K |
2026 Q3
0 quarters
|
|
572
First Horizon
FHN
$11B
| $216K | 0.01% |
+9,400
| New | +$235K |
2026 Q3
0 quarters
|
|
573
UMB Financial
UMBF
$10.1B
| $216K | 0.01% |
+1,662
| New | +$237K |
2026 Q3
0 quarters
|
|
574
Progressive
PGR
$137B
| $216K | 0.01% |
+1,041
| New | +$225K |
2026 Q3
0 quarters
|
|
575
Neurocrine Biosciences
NBIX
$16.9B
| $216K | 0.01% |
1,521
+21
| +1% | +$3.38K |
2026 Q1
2 quarters
|
|
Similar funds
MBL Wealth's Q3 2026 Portfolio in Review
As of Q3 2026, MBL Wealth held 624 positions worth $1.67B, up 14% from $1.47B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
MBL Wealth deployed $216M of net new capital in Q3 2026, opening 238 new positions and adding to 212 existing holdings. Its largest new stake was iShares iBonds Oct 2032 Term TIPS ETF: 347,360 shares worth $8.53M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 82% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $16.5M trimmed.
- MBL Wealth's largest Q3 2026 buy was iShares iBonds Oct 2032 Term TIPS ETF: 347,360 shares worth $8.53M.
- MBL Wealth added most to F/m US Treasury 3 Month Bill Fund in Q3 2026, an estimated $13.3M increase.
- MBL Wealth's biggest Q3 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $16.5M.
- MBL Wealth fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q3 2026, selling an estimated $661K.
- MBL Wealth's ten largest holdings make up 42% of its $1.67B portfolio in Q3 2026.
- MBL Wealth opened 238 new positions and closed 23 in Q3 2026.
- MBL Wealth's portfolio value rose 14% quarter-over-quarter to $1.67B.
Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.